{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T20:55:14Z","timestamp":1778532914485,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing Key Laboratory of Critical Bridging Technologies for Chronic Disease Drug Development"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-01432-1","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T14:50:43Z","timestamp":1747147843000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["LC\u2013MS\/MS quantification of 20(S)-protopanaxadiol in complex biological matrices for bioanalytical method validation and pharmacokinetic analysis"],"prefix":"10.1038","volume":"15","author":[{"given":"Pengfei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengxi","family":"niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sha","family":"Sha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"issue":"2","key":"1432_CR1","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1254\/jphs.fmj04001x4","volume":"95","author":"H Hasegawa","year":"2004","unstructured":"Hasegawa, H. Proof of the mysterious efficacy of ginseng: basic and clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal bacteria and esterification with fatty acid. J Pharmacol Sci. 95(2), 153\u2013157. https:\/\/doi.org\/10.1254\/jphs.fmj04001x4 (2004).","journal-title":"J Pharmacol Sci."},{"key":"1432_CR2","doi-asserted-by":"publisher","first-page":"865070","DOI":"10.3389\/fnut.2022.865070","volume":"9","author":"R Huang","year":"2022","unstructured":"Huang, R. et al. Studies on bioactive components of red ginseng by uhplc-ms and its effect on lipid metabolism of type 2 diabetes mellitus. Front Nutr. 9, 865070. https:\/\/doi.org\/10.3389\/fnut.2022.865070 (2022).","journal-title":"Front Nutr."},{"issue":"14","key":"1432_CR3","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.3390\/molecules24142618","volume":"24","author":"S Jin","year":"2019","unstructured":"Jin, S. et al. Detection of 13 ginsenosides (Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg3, Rh2, F1, compound K, 20 (S)-protopanaxadiol, and 20 (S)-protopanaxatriol) in human plasma and application of the analytical method to human pharmacokine. Molecules 24(14), 2618. https:\/\/doi.org\/10.3390\/molecules24142618 (2019).","journal-title":"Molecules"},{"issue":"3","key":"1432_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1055\/s-2001-12005","volume":"67","author":"JY Cho","year":"2001","unstructured":"Cho, J. Y. et al. In vitro inhibitory effect of protopanaxadiol ginsenosides on tumor necrosis factor (TNF)-alpha roduction and its modulation by known TNF-alpha antagonists. Planta Med. 67(3), 213\u2013218. https:\/\/doi.org\/10.1055\/s-2001-12005 (2001).","journal-title":"Planta Med."},{"issue":"2","key":"1432_CR5","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/carcin\/bgh313","volume":"26","author":"JY Lee","year":"2005","unstructured":"Lee, J. Y. et al. Antitumor promotional effects of a novel intestinal bacterial metabolite (IH-901) derived from the protopanaxadiol-type ginsenosides in mouse skin. Carcinogenesis 26(2), 359\u2013367. https:\/\/doi.org\/10.1093\/carcin\/bgh313 (2005) (Epub 2004 Oct 21).","journal-title":"Carcinogenesis"},{"issue":"10","key":"1432_CR6","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1248\/cpb.14.1150","volume":"14","author":"O Tanaka","year":"1966","unstructured":"Tanaka, O., Nagai, M. & Shibata, S. Chemical studies on the oriental plant drugs: The stereochemistry of protopanaxadiol, a genuine sapogenin of ginseng. Chem Pharm Bull. 14(10), 1150\u20131156. https:\/\/doi.org\/10.1248\/cpb.14.1150 (1966).","journal-title":"Chem Pharm Bull."},{"issue":"23","key":"1432_CR7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/s0378-8741(02)00317-3","volume":"84","author":"QF Xu","year":"2003","unstructured":"Xu, Q. F., Fang, X. L. & Chen, D. F. Pharmacokinetics and bioavailability of ginsenoside Rb, and Rg, from Panax notoginseng in rats. J Ethnopharmacology. 84(23), 187\u2013192. https:\/\/doi.org\/10.1016\/s0378-8741(02)00317-3 (2003).","journal-title":"J Ethnopharmacology."},{"issue":"7","key":"1432_CR8","doi-asserted-by":"publisher","first-page":"749","DOI":"10.2116\/analsci.26.749","volume":"26","author":"M Han","year":"2010","unstructured":"Han, M., Chen, J., Chen, S. & Wang, X. Development of a UPLC-ESI-MS\/MS assay for 20(S)-protopanaxadiol and pharmacokinetic application of its two formulations in rats. Anal Sci. 26(7), 749\u2013753. https:\/\/doi.org\/10.2116\/analsci.26.749 (2010).","journal-title":"Anal Sci."},{"issue":"8","key":"1432_CR9","doi-asserted-by":"publisher","first-page":"e4252","DOI":"10.1002\/bmc.4252","volume":"32","author":"JQ Li","year":"2018","unstructured":"Li, J. Q. et al. Simultaneous determination of 20(S)-protopanaxadiol and its three metabolites in rat plasma by LC-MS\/MS: application to their pharmacokinetic studies. Biomed Chromatogr. 32(8), e4252. https:\/\/doi.org\/10.1002\/bmc.4252 (2018) (Epub 2018 May 2).","journal-title":"Biomed Chromatogr."},{"key":"1432_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3908142","author":"ID Choi","year":"2016","unstructured":"Choi, I. D. et al. Enhanced absorption study of ginsenoside compound K (20-O-\u03b2-(D-Glucopyranosyl)-20(S)-protopanaxadiol) after oral administration of fermented red ginseng extract (HYFRG\u2122) in Healthy Korean Volunteers and Rats. Evid Based Complement Alternat Med. https:\/\/doi.org\/10.1155\/2016\/3908142 (2016) (Epub 2016 Jul 19).","journal-title":"Evid Based Complement Alternat Med."},{"issue":"2","key":"1432_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/s0021-9673(00)01208-5","volume":"910","author":"D Shangguan","year":"2001","unstructured":"Shangguan, D. et al. New method for high-performance liquid chromatographic separation and fluorescence detection of ginsenosides. J Chromatogr A. 910(2), 367\u2013372. https:\/\/doi.org\/10.1016\/s0021-9673(00)01208-5 (2001).","journal-title":"J Chromatogr A."},{"issue":"2","key":"1432_CR12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/s0378-4347(96)00304-0","volume":"689","author":"JF Cui","year":"1997","unstructured":"Cui, J. F., Bj\u00f6rkhem, I. & Eneroth, P. Gas chromatographic-mass spectrometric determination of 20(S)-protopanaxadiol and 20(S)-protopanaxatriol for study on human urinary excretion of ginsenosides after ingestion of ginseng preparations. J Chromatogr B Biomed Sci Appl. 689(2), 349\u2013355. https:\/\/doi.org\/10.1016\/s0378-4347(96)00304-0 (1997).","journal-title":"J Chromatogr B Biomed Sci Appl."},{"issue":"5\u20136","key":"1432_CR13","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.jchromb.2009.01.009","volume":"877","author":"D Zhang","year":"2009","unstructured":"Zhang, D. et al. Rapid and sensitive LC-MS\/MS assay for the quantitation of 20(S)-protopanaxadiol in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877(5\u20136), 581\u2013585. https:\/\/doi.org\/10.1016\/j.jchromb.2009.01.009 (2009) (Epub 2009 Jan 14).","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"issue":"1437","key":"1432_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.chroma.2016.02.017","volume":"11","author":"XE Zhao","year":"2016","unstructured":"Zhao, X. E. et al. Dual ultrasonic-assisted dispersive liquid-liquid microextraction coupled with microwave-assisted derivatization for simultaneous determination of 20(S)-protopanaxadiol and 20(S)-protopanaxatriol by ultra high performance liquid chromatography-tandem mass spectrometry. J Chromatogr A. 11(1437), 49\u201357. https:\/\/doi.org\/10.1016\/j.chroma.2016.02.017 (2016) (Epub 2016 Feb 6).","journal-title":"J Chromatogr A."},{"issue":"14","key":"1432_CR15","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1055\/s-0033-1350675","volume":"79","author":"Xu Cai Xiaojun","year":"2013","unstructured":"Cai Xiaojun, Xu., Yuping, P. Y., Yiping, R. & Zheng, X. An UFLC-MS\/MS method for quantification of panaxadiol in rat plasma and its application to a pharmacokinetic study. Planta Med. 79(14), 1324\u20131328. https:\/\/doi.org\/10.1055\/s-0033-1350675 (2013) (Epub 2013 Aug 7).","journal-title":"Planta Med."},{"issue":"5","key":"1432_CR16","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.jpba.2008.09.045","volume":"48","author":"HC Ren","year":"2008","unstructured":"Ren, H. C. et al. Sensitive determination of 20(S)-protopanaxadiol in rat plasma using HPLC-APCI-MS: Application of pharmacokinetic study in rats. J Pharm Biomed Anal. 48(5), 1476\u20131480. https:\/\/doi.org\/10.1016\/j.jpba.2008.09.045 (2008) (Epub 2008 Oct 8).","journal-title":"J Pharm Biomed Anal."},{"issue":"3","key":"1432_CR17","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/jms.3174","volume":"48","author":"Y Bao","year":"2013","unstructured":"Bao, Y., Wang, Q. & Tang, P. Lithium adduct as precursor ion for sensitive and rapid quantification of 20 (S)-protopanaxadiol in rat plasma by liquid chromatography\/quadrupole linear ion trap mass spectrometry and application to rat pharmacokinetic study. J Mass Spectrom. 48(3), 399\u2013405. https:\/\/doi.org\/10.1002\/jms.3174 (2013).","journal-title":"J Mass Spectrom."},{"issue":"887\u2013888","key":"1432_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jchromb.2011.12.032","volume":"1","author":"W Wang","year":"2012","unstructured":"Wang, W., Shao, Y., Ma, S., Xiangmeng, Wu. & Meng, Q. Determination of 20(S)-protopanaxadiol ocotillol type epimers in rat plasma by liquid chromatography tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 1(887\u2013888), 19\u201324. https:\/\/doi.org\/10.1016\/j.jchromb.2011.12.032 (2012) (Epub 2012 Jan 16).","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"issue":"5","key":"1432_CR19","doi-asserted-by":"publisher","first-page":"365","DOI":"10.4155\/bio-2018-0185","volume":"11","author":"Li Yang","year":"2019","unstructured":"Yang, Li. et al. LC-MS\/MS determination of ginsenoside compound K and its metabolite 20 (S)-protopanaxadiol in human plasma and urine: applications in a clinical study. Bioanalysis 11(5), 365\u2013380. https:\/\/doi.org\/10.4155\/bio-2018-0185 (2019) (Epub 2019 Mar 15).","journal-title":"Bioanalysis"},{"issue":"1","key":"1432_CR20","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12917-020-02451-y","volume":"16","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert, N. et al. The ARRIVE guidelines 20: Updated guidelines for reporting animal research. BMC Vet Res. 16(1), 242. https:\/\/doi.org\/10.1186\/s12917-020-02451-y (2020).","journal-title":"BMC Vet Res."},{"key":"1432_CR21","doi-asserted-by":"publisher","unstructured":"Li, P., Zhang, M., Chen, M., Liu, G., Meng*, L., Zhang*, D. Systematic studies on the kinetic process of 20(S)-protopanaxadiol in rats and dogs: absorption, distribution, metabolism and excretion. Front. Pharmacol. 2024: 1430780. https:\/\/doi.org\/10.3389\/fphar.2024.1430780.","DOI":"10.3389\/fphar.2024.1430780"},{"issue":"11","key":"1432_CR22","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1373\/clinchem.2005.056556","volume":"51","author":"Y Wang","year":"2005","unstructured":"Wang, Y., Zhong, D., Fawcett, J. P. & Gu, J. Autosampler programming for improved sample throughput in liquid chromatography\/mass spectrometry. Clin Chem. 51(11), 2216\u20132218. https:\/\/doi.org\/10.1373\/clinchem.2005.056556 (2005).","journal-title":"Clin Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01432-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01432-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01432-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T14:50:43Z","timestamp":1747147843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01432-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1432"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-01432-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"assertion":[{"value":"6 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Experiments complied with Chinese Physiological Society\u2019s lab animal guidelines and received ethics approval from Jilin Uni\u2019s Lab Animal Ethics Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}}],"article-number":"16640"}}